APA (7th ed.) Citation

Ozkerim, U., Isik, D., Kinikoglu, O., Oksuz, S., Altintas, Y. E., Akdag, G., . . . Turan, N. (2026). Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study. Journal of Personalized Medicine, 16(1), 8. https://doi.org/10.3390/jpm16010008

Chicago Style (17th ed.) Citation

Ozkerim, Ugur, et al. "Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study." Journal of Personalized Medicine 16, no. 1 (2026): 8. https://doi.org/10.3390/jpm16010008.

MLA (9th ed.) Citation

Ozkerim, Ugur, et al. "Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study." Journal of Personalized Medicine, vol. 16, no. 1, 2026, p. 8, https://doi.org/10.3390/jpm16010008.